Home LiteratureArticle Details
PMID: 21361747 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.

Cytotherapy ·Vol. 13 ·No. 5 ·2011-05-00 ·Pages 518-22

Bollard CM, Gottschalk S, Helen Huls M, Leen AM, Gee AP, Rooney CM

Abstract

暂无摘要

MeSH Terms
Antigen-Presenting Cells/immunology Cell Culture Techniques Cell Line, Tumor Cell Separation/methods Epstein-Barr Virus Infections/complications,therapy Herpesvirus 4, Human/immunology Humans Immunotherapy, Adoptive/methods Lymphoma/therapy,virology T-Lymphocytes, Cytotoxic/immunology,transplantation Transduction, Genetic Viral Matrix Proteins/immunology
Chemicals
EBV-associated membrane antigen, Epstein-Barr virus Viral Matrix Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bollard Catherine M
Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, Texas 77030, USA. cmbollar@txccc.org
Gottschalk Stephen
Helen Huls M
Leen Ann M
Gee Adrian P
Rooney Cliona M
References (11)
11 references, click to expand
  1. Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).
    J Immunother. 2010 Apr;33(3):305-15 PMID: 20445351
  2. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.
    J Immunol Methods. 1990 Apr 17;128(2):189-201 PMID: 1691237
  3. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
    J Exp Med. 2004 Dec 20;200(12):1623-33 PMID: 15611290
  4. The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
    J Immunother. 2004 Jul-Aug;27(4):317-27 PMID: 15235393
  5. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
    Blood. 2007 Oct 15;110(8):2838-45 PMID: 17609424
  6. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy.
    J Immunother. 2003 May-Jun;26(3):241-56 PMID: 12806278
  7. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.
    Blood. 1998 Apr 15;91(8):2925-34 PMID: 9531603
  8. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1973 Jan;70(1):190-4 PMID: 4346033
  9. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
    Blood. 2003 Mar 1;101(5):1905-12 PMID: 12411306
  10. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.
    J Hematother. 1995 Apr;4(2):73-9 PMID: 7633844
  11. Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells.
    J Immunother. 2007 Jan;30(1):96-107 PMID: 17198088
Article Info
Journal
Cytotherapy
Abbr.
Cytotherapy
ISSN
1477-2566
DOI
10.3109/14653249.2011.561983
Email
cmbollar@txccc.org
Published
2011-05-00
Epub
2011-00-01
Pages
518-22
Language
English
Region
England
NLM ID
100895309
PMCID
PMC3186062
Subset
IM
Grants
NCI NIH HHS · P50 CA126752-01 · United States
NCRR NIH HHS · U42 RR16578 · United States
NHLBI NIH HHS · N01-HB-37163 · United States
NCI NIH HHS · P01 CA094237 · United States
NCI NIH HHS · P01 CA94237 · United States
NHLBI NIH HHS · N01HB37163 · United States
NCRR NIH HHS · U42 RR016578 · United States
NCI NIH HHS · P50 CA126752 · United States
NCI NIH HHS · P50CA126752 · United States
External Links
PubMed source DOI: 10.3109/14653249.2011.561983 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2